“COST-EFFECTIVENESS ANALYSIS OF AVELUMAB TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA”. 2020. Voprosy Onkologii 66 (2): 109-19. https://doi.org/10.37469/0507-3758-2020-66-2-109-119.